Morten Otto Alexander

Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development.

Morten Otto Alexander, 2016 .

A high-throughput platform to select for regulators of crispr-cas associated activity

S. Woo, Morten Otto Alexander, V. D. Helm, 2019 .

TITLE : Inhibitors of CRISPR-Cas associated activity

Morten Otto Alexander, V. D. Helm, Vazquez-Uribe, 2019 .

May 09, 2020 Recombination-stable multimeric green fluorescent protein for characterization of weak promoter outputs

Peter Rugbjerg, Morten Otto Alexander, Jochen Christoph Förster, 2016 .